Media centre

Press releases

16/05/2008

Antisoma to present at Rodman & Renshaw 5th Annual Global Healthcare Conference in Monte Carlo

London, UK: 16 May 2008 - Antisoma plc (LSE: ASM; USOTC: ATSMY) announces that its Chief Executive, Glyn Edwards, will be presenting at Rodman & Renshaw 5th Annual Global Healthcare Conference in Monte Carlo, Monaco.

The presentation is scheduled for 12:50 CET (11:50 BST) on Monday, May 19th, and a webcast will be available to all on Antisoma’s website at http://www.antisoma.com/asm/media/.

For live viewing of the webcast, it is recommended that viewers log on 15 minutes early in order to register and download any necessary software.

Background on Antisoma
Headquartered in London, UK, Antisoma is a biopharmaceutical company that develops novel products for the treatment of cancer. Antisoma fills its development pipeline by acquiring promising new product candidates from internationally recognised academic or cancer research institutions. Its core activity is the preclinical and clinical development of these drug candidates. Please visit www.antisoma.com for further information.